Viewing StudyNCT06597513


Ignite Creation Date: 2025-12-18 @ 9:44 AM
Ignite Modification Date: 2025-12-23 @ 9:50 PM
Study NCT ID: NCT06597513
Status: None
Last Update Posted: 2024-10-15 00:00:00
First Post: 2024-09-12 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Auto-HSCT-Supported Dose-Dense Chemotherapy with Adebrelimab As First-Line Treatment for ES-SCLC
Sponsor:
Organization: